Literature DB >> 7950827

Multiple reflective channels in the spleen: a sonographic sign of portal hypertension.

R P Kedar1, S A Merchant, H H Malde, V H Patel.   

Abstract

We consistently observed small "reflective channels" (RCs) in the splenic parenchyma in patients with portal hypertension (PHT). The purpose of this study was to investigate the frequency of this sign in PHT and in splenic disorders unrelated to PHT compared to normal controls. The significance of this sign in the diagnosis of PHT and in differentiating PHT splenomegalies from others was also assessed. A total of 337 patients underwent sonographic examination of the spleen: 147 normal, 75 non-PHT splenic pathologies, and 115 with PHT. The RCs were scored from grade 0 to 3 by counting the number in an area of 12 mm2 in the splenic parenchyma. Of 222 normal and non-PHT spleens, 174 (78%) showed grade 0, 44 (20%) grade 1, four grade 2 (1%), and none showed grade 3 RCs. Of 115 PHT cases, 17 showed grade 0, 25 grade 1, 44 grade 2, and 29 showed grade 3 RCs. The sensitivity of this sign was 0.85 with a specificity of 0.77 and an accuracy of 0.80 in detecting PHT (p < 0.001). The interobserver and intraobserver variation for grading was insignificant (p > 0.1). The RCs could be explained by periarterial fibrosis and dilatation of venous sinuses with increased collagen in their walls, which is known to occur in PHT. The vascular nature on ultrasound (US) was confirmed by the presence of flow on color Doppler. This sign is readily differentiated from the calcifications of tuberculosis, histoplasmosis, sickle cell infarcts, and phleboliths; it serves as a useful aid in diagnosing and differentiating PHT splenomegaly from non-PHT splenomegaly.

Entities:  

Mesh:

Year:  1994        PMID: 7950827     DOI: 10.1007/BF00206939

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  9 in total

Review 1.  Duplex assessment of the portal venous system.

Authors:  D B Koslin; S A Mulligan; L L Berland
Journal:  Semin Ultrasound CT MR       Date:  1992-02       Impact factor: 1.875

2.  Siderotic nodules in the spleen: MR imaging of portal hypertension.

Authors:  M Minami; Y Itai; K Ohtomo; S Ohnishi; T Niki; T Kokubo; K Yoshikawa; M Iio
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

3.  Gamna-Gandy bodies of the spleen: evaluation with MR imaging.

Authors:  T Sagoh; K Itoh; K Togashi; T Shibata; K Nishimura; S Minami; R Asato; S Noma; I Fujisawa; K Yamashita
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

4.  Unusual sonographic appearance of the spleen in a case of myelofibrosis.

Authors:  T B Hunter; K Haber
Journal:  AJR Am J Roentgenol       Date:  1977-01       Impact factor: 3.959

5.  Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration.

Authors:  L Bolondi; L Gandolfi; V Arienti; G C Caletti; E Corcioni; G Gasbarrini; G Labò
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

6.  Ultrasonic-pathologic classification of splenic abnormalities: gray-scale patterns.

Authors:  C A Mittelstaedt; C L Partain
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

7.  Splenic lesions: sonographic patterns, follow-up, differential diagnosis.

Authors:  C Goerg; W B Schwerk; K Goerg
Journal:  Eur J Radiol       Date:  1991 Jul-Aug       Impact factor: 3.528

8.  Increased echogenicity of the spleen in benign and malignant disease.

Authors:  J Siler; T B Hunter; J Weiss; K Haber
Journal:  AJR Am J Roentgenol       Date:  1980-05       Impact factor: 3.959

9.  Effects of a meal on normal and hypertensive portal venous system: a quantitative ultrasonographic assessment.

Authors:  A K Goyal; D S Pokharna; S K Sharma
Journal:  Gastrointest Radiol       Date:  1989
  9 in total
  1 in total

Review 1.  Invasive and non-invasive assessment of portal hypertension.

Authors:  Jonathan Chung-Fai Leung; Thomson Chi-Wang Loong; James Pang; Jeremy Lok Wei; Vincent Wai-Sun Wong
Journal:  Hepatol Int       Date:  2017-03-30       Impact factor: 6.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.